Researchers are working on an “on and off” switch to improve the safety and efficacy of chimeric antigen receptor (CAR) T-cell therapy and counter...
Day: 23 August 2018
Dr. Madduri on Eligibility for CAR T-Cell Therapy in Myeloma
Deepu Madduri, MD, assistant professor, Mount Sinai Hospital, discusses eligibly criteria for patients with multiple myeloma to receive chimeric...